Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-30 @ 9:48 AM
Study NCT ID:
NCT02327169
Status:
COMPLETED
Last Update Posted:
2020-02-25
First Post:
2014-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-23
First Submit QC Date:
None
Study First Post Date:
2014-12-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-26
Results First Submit QC Date:
None
Results First Post Date:
2020-02-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-11
Last Update Post Date:
2020-02-25
Last Update Post Date Type:
ACTUAL